Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProFunds Biotechnology UltraSector ProFund

+ Add to Watchlist

BIPSX:US

56.69 USD 1.57 2.69%

As of 09:29:30 ET on 05/05/2015.

Snapshot for ProFunds Biotechnology UltraSector ProFund (BIPSX)

Year To Date: +6.98% 3-Month: +3.07% 3-Year: +62.43% 52-Week Range: 35.56 - 63.52
1-Month: +1.25% 1-Year: +62.90% 5-Year: +42.64% Beta vs DJUSBT: 1.34

Mutual Fund Chart for BIPSX

No chart data available.
  • BIPSX:US 56.69
  • 1M
  • 1Y
Interactive BIPSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIPSX

ProFunds Biotechnology UltraSector ProFund is an open-end fund incorporated in the USA. The Fund's objective is daily investment results, before fees and expenses, that correspond to one and one-half times (150%) of the performance of the Dow Jones U.S. Biotechnology Index. The Fund invests in biotechnology companies or in instruments that provide exposure to these companies.

Inception Date: 06-19-2000 Telephone: 1-240-497-6400
Managers: TODD BRUCE JOHNSON / HOWARD S RUBIN
Web Site: www.profunds.com

Fundamentals for BIPSX

NAV (on 2015-05-05) 56.69
Assets (M) (on 2015-03-31) 767.59
Fund Leveraged Y
Fund Leverage Percent Y
Minimum Investment 5,000.00
Minimum Subsequent Investment 0.00

Dividends for BIPSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-15) 6.58
Dividend Yield (ttm) 11.66

Fees & Expenses for BIPSX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.57

Top Fund Holdings for BIPSX

Filing Date: 01/31/2015
Name Position Value % of Total
Gilead Sciences Inc 902,556 94,614,945 11.673%
Amgen Inc 454,572 69,213,133 8.539%
AbbVie Inc 951,966 57,451,148 7.088%
Celgene Corp 477,630 56,914,391 7.022%
Biogen Inc 141,642 55,121,401 6.800%
Alexion Pharmaceuticals Inc 118,584 21,729,332 2.681%
Regeneron Pharmaceuticals Inc 44,469 18,528,454 2.286%
Illumina Inc 85,644 16,716,852 2.062%
Vertex Pharmaceuticals Inc 143,289 15,781,850 1.947%
BioMarin Pharmaceutical Inc 93,879 9,121,284 1.125%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil